Multi-immunohistochemistry (mIHC) is a crucial technique for simultaneous detection of multiple cellular phenotypes within a single tissue section. Its application in cancer diagnosis and treatment underscores the importance of developing reliable automated cell detection and classification methods for mIHC images. However, existing approaches face significant challenges due to high cell density, heterogeneity, and the laborious nature of annotation. This study presents a novel automated cell detection and classification model specifically designed to address these limitations. The proposed model leverages a simplified point-based annotation approach, significantly reducing annotation effort compared to conventional methods. A hybrid masking strategy combining Gaussian and circular masks is introduced to accurately capture the diverse morphological characteristics of different cell types. To enhance detail detection against complex backgrounds and robustness in highly heterogeneous environments, a novel Upsampling Attention Gate (UAG) is proposed. This module effectively improves feature extraction by focusing on relevant information within the image. Finally, a post-processing module is incorporated to address cell adhesion issues during detection, further enhancing the accuracy of the model. Extensive experiments on the mIHC dataset demonstrate that the proposed method achieves F1 scores of 0.772 and 0.747 for cell detection and classification, respectively, outperforming existing methods across various performance metrics. This study offers a promising solution to the challenges of automated cell detection and classification in mIHC images, paving the way for improved diagnosis and treatment in cancer research. The code has been made publicly available: https://github.com/s153g/mIHC_Cell_Recognition.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/JBHI.2025.3527706 | DOI Listing |
FASEB J
March 2025
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, USA.
Butyrophilin 3A1 (BTN3A1) is an integral membrane protein capable of detecting phosphoantigens, like (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP), through its internal B30.2 domain. Detection of phosphoantigens leads to interactions with butyrophilin 2A1 and the subsequent activation of γδ-T cells.
View Article and Find Full Text PDFCancer Med
March 2025
Universidad Autónoma del Estado de Morelos, Facultad de Medicina, Cuernavaca, Morelos, Mexico.
Introduction: Osteosarcoma, a highly aggressive bone cancer primarily affecting children and young adults, remains a significant challenge in clinical oncology. Metastasis stands as the primary cause of mortality in osteosarcoma patients. However, the mechanisms driving this process remain incompletely understood.
View Article and Find Full Text PDFDiagn Cytopathol
March 2025
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
Introduction: Soft tissue lesions encompass a diverse category of diseases from benign to malignant, and their morphology might overlap; therefore, accurate categorization is needed to approach the reporting of soft tissue cytology. The cytology of these lesions is helpful in detecting the features of malignancy, which helps in guiding further management. In this study, we applied the proposed IAC-IARC-WHO cytopathology system to assess the risk of malignancy (ROM) and diagnostic accuracy (DA) for the determination of its clinical and diagnostic utility.
View Article and Find Full Text PDFBiol Reprod
March 2025
Cell Biology Laboratory, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium.
CRISP2 is enriched in the male reproductive system of mammals and plays roles in spermatogenesis, sperm motility, and fertilization. Although extensively investigated in rodents and boars, human CRISP2 (hCRISP2) remains poorly studied, particularly concerning its localization in testicular and epididymal tissues and its molecular features. In this study, we used immunofluorescence to determine the localization of hCRISP2 in testis, epididymis, and ejaculated sperm.
View Article and Find Full Text PDFHaematologica
March 2025
Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra.
Continuous treatment with ibrutinib not only exerts tumor control but also enhances T cell function in patients with chronic lymphocytic leukemia (CLL). We conducted longitudinal multi-omics analyses in samples from CLL patients receiving ibrutinib upfront to identify potential adaptive mechanisms to Bruton tyrosine kinase (BTK) inhibition during the first 12 months of continuous therapy. We found that ibrutinib induced a decrease in the expression of exhaustion markers and the proportion of Tregs and Tfh cells normalized to levels observed in healthy donors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!